- United Kingdom
- /
- Medical Equipment
- /
- AIM:TSTL
January 2025's Rising Stars: UK Penny Stocks To Watch
Reviewed by Simply Wall St
The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic interdependencies. Amidst these broader market fluctuations, penny stocks offer a unique investment opportunity by focusing on smaller or newer companies that might be overlooked. Despite being considered an outdated term, penny stocks can still provide growth potential when backed by strong financial health and sound fundamentals.
Top 10 Penny Stocks In The United Kingdom
Name | Share Price | Market Cap | Financial Health Rating |
ME Group International (LSE:MEGP) | £2.06 | £776.24M | ★★★★★★ |
Begbies Traynor Group (AIM:BEG) | £0.946 | £150.76M | ★★★★★★ |
Stelrad Group (LSE:SRAD) | £1.405 | £178.93M | ★★★★★☆ |
Foresight Group Holdings (LSE:FSG) | £3.74 | £426.51M | ★★★★★★ |
Next 15 Group (AIM:NFG) | £3.60 | £358.04M | ★★★★☆☆ |
Secure Trust Bank (LSE:STB) | £4.62 | £88.11M | ★★★★☆☆ |
Ultimate Products (LSE:ULTP) | £1.08 | £92.27M | ★★★★★★ |
Tristel (AIM:TSTL) | £3.95 | £188.38M | ★★★★★★ |
Luceco (LSE:LUCE) | £1.274 | £196.49M | ★★★★★☆ |
Helios Underwriting (AIM:HUW) | £2.18 | £155.53M | ★★★★★☆ |
Click here to see the full list of 441 stocks from our UK Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Devolver Digital (AIM:DEVO)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Devolver Digital Inc. is a company that develops and publishes video games for PC and mobile devices both in the United States and internationally, with a market cap of £118.63 million.
Operations: Devolver Digital Inc. has not reported any specific revenue segments.
Market Cap: £118.63M
Devolver Digital, with a market cap of £118.63 million, is currently unprofitable yet maintains a strong cash position with short-term assets of $54.9M exceeding both its short-term and long-term liabilities. Despite being debt-free and having an experienced management team, the company has faced increasing losses over the past five years at a rate of 41.6% annually. Its stock trades significantly below estimated fair value while earnings are forecast to grow substantially by 96.54% per year, indicating potential for future improvement despite current challenges in profitability and return on equity issues.
- Get an in-depth perspective on Devolver Digital's performance by reading our balance sheet health report here.
- Review our growth performance report to gain insights into Devolver Digital's future.
tinyBuild (AIM:TBLD)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: tinyBuild, Inc. is involved in the development and publishing of video games on a global scale, with a market cap of £24.58 million.
Operations: The company generates revenue from its Computer Graphics segment, amounting to $40.20 million.
Market Cap: £24.58M
tinyBuild, Inc., with a market cap of £24.58 million, is currently unprofitable and faces financial challenges but remains debt-free. Its short-term assets of $19.2M exceed both short-term and long-term liabilities, providing some financial stability despite having less than a year of cash runway based on current free cash flow. The company’s stock trades significantly below estimated fair value; however, it continues to experience high volatility in its share price. Revenue is forecast to grow modestly at 5.25% annually, yet profitability remains elusive with no expected turnaround in the next three years as losses have increased over the past five years by 68.2% annually.
- Dive into the specifics of tinyBuild here with our thorough balance sheet health report.
- Learn about tinyBuild's future growth trajectory here.
Tristel (AIM:TSTL)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Tristel plc develops, manufactures, and sells infection prevention products across the United Kingdom, Australia, Germany, Western Europe, and internationally with a market cap of £188.38 million.
Operations: The company generates revenue primarily from Hospital Medical Device Decontamination (£36.34 million) and Hospital Environmental Surface Disinfection (£3.44 million).
Market Cap: £188.38M
Tristel plc, with a market cap of £188.38 million, demonstrates financial stability and growth potential in the penny stock arena. The company boasts strong earnings growth of 45.5% over the past year, surpassing industry averages, and maintains high-quality earnings with a substantial Return on Equity of 20%. Tristel's short-term assets significantly exceed both its short- and long-term liabilities, reinforcing its solid financial footing without any debt burden. However, despite trading below estimated fair value and having improved profit margins to 15.5%, the dividend yield is not well covered by earnings. Management's limited experience could be a concern for some investors.
- Unlock comprehensive insights into our analysis of Tristel stock in this financial health report.
- Explore Tristel's analyst forecasts in our growth report.
Next Steps
- Unlock our comprehensive list of 441 UK Penny Stocks by clicking here.
- Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Tristel might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About AIM:TSTL
Tristel
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
Outstanding track record with flawless balance sheet.
Market Insights
Community Narratives


